SCHEMBL6705392

SCHEMBL6705392

O=C1C=CC(=O)N1c1ccc([C](c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDAH1 O94760 1/20 0.66
MGLL Q99685 13/20 0.65
FAAH O00519 7/20 0.62
HSP90AA1 P07900 6/20 0.56
NPSR1 Q6W5P4 3/20 0.55
TDP1 Q9NUW8 3/20 0.55
PKM P14618 3/20 0.55
MAPK1 P28482 1/20 0.55
ALDH1A1 P00352 3/20 0.49
HTT P42858 2/20 0.49
HPGD P15428 1/20 0.49
CACNA1B Q00975 1/20 0.49
APBA1 Q02410 1/20 0.49
ATM Q13315 2/20 0.47
CCR6 P51684 1/20 0.47
TLR9 Q9NR96 1/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL339889 0.86 DDAH1 (0.69) DDAH1MGLLFAAHHSP90AA1NPSR1
SCHEMBL12273000 0.80 MGLL (0.67) DDAH1MGLLFAAHHSP90AA1NPSR1
Benzene SCHEMBL28088808 0.80 MGLL (1.00) DDAH1MGLLFAAHHSP90AA1NPSR1
SCHEMBL8920586 0.80 MGLL (1.00) DDAH1MGLLFAAHHSP90AA1NPSR1
SCHEMBL18713 0.80 MGLL (1.00) DDAH1MGLLFAAHHSP90AA1NPSR1
SCHEMBL235166 0.79 DDAH1 (1.00) DDAH1MGLLFAAHHSP90AA1NPSR1
SCHEMBL8058716 0.78 CA12 (0.67) MAPK1ALDH1A1HPGDCA12CA1
SCHEMBL15841338 0.78 MGLL (0.95) DDAH1MGLLFAAHHSP90AA1NPSR1
Hydrochloric Acid SCHEMBL8536567 0.78 MGLL (0.95) DDAH1MGLLFAAHHSP90AA1NPSR1
SCHEMBL30657178 0.78 MGLL (0.95) DDAH1MGLLFAAHHSP90AA1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040116685-A1 Method for solution phase synthesis of oligonucleotides PROLIGO LLC 2004-06-17 US disclosed
EP-0996627-A4 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES AND PEPTIDES PROLIGO L L C (US) 2002-01-02 EP disclosed
US-6262251-B1 PRODUCT ANCHORED SEQUENCIAL SYNTHESIS (PASS); AN ANCHOR GROUP ATTACHED TO THE 5' END OF THE GROWING OLIGONUCLEOTIDE PRODUCT ALLOWS THE COUPLED PRODUCT TO BE SEPARATED FROM UNREACTED STARTING MATERIALS PROLIGO LLC 2001-07-17 US disclosed
EP-0979233-A4 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES PROLIGO L L C (US) 2001-03-21 EP disclosed
EP-0996627-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES AND PEPTIDES Proligo L.L.C. (US) 2000-05-03 EP disclosed
EP-0979233-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES NeXstar Pharmaceuticals, Inc. (US) 2000-02-16 EP disclosed
WO-1998047910-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES PROLIGO LLC (US) 1998-10-29 WO disclosed
EP-0863910-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES NeXstar Pharmaceuticals, Inc. (US) 1998-09-16 EP disclosed
WO-1998030578-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES AND PEPTIDES PROLIGO LLC (US) 1998-07-16 WO disclosed
WO-1997014706-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES NEXSTAR PHARMACEUTICALS, INC. (US) 1997-04-24 WO disclosed